Supernus Pharmaceuticals
SUPN
#4182
Rank
HK$20.38 B
Marketcap
HK$355.60
Share price
1.29%
Change (1 day)
23.54%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$2.88 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are HK$2.88 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$2.58 B-7.24%
2023-12-31HK$2.78 B-56.39%
2022-12-31HK$6.37 B-6.34%
2021-12-31HK$6.80 B15.7%
2020-12-31HK$5.88 B33.79%
2019-12-31HK$4.39 B7.05%
2018-12-31HK$4.10 B235.06%
2017-12-31HK$1.22 B34.25%
2016-12-31HK$0.91 B17.15%
2015-12-31HK$0.77 B4.64%
2014-12-31HK$0.74 B23.96%
2013-12-31HK$0.60 B112.97%
2012-12-31HK$0.28 B-17.93%
2011-12-31HK$0.34 B-51.6%
2010-12-31HK$0.71 B6.52%
2009-12-31HK$0.66 B2.94%
2008-12-31HK$0.64 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
United Therapeutics
UTHR
HK$5.92 B 105.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$709.05 B 24,511.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$609.44 B 21,054.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$256.24 B 8,794.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$883.85 B 30,579.00%๐Ÿ‡บ๐Ÿ‡ธ USA